Long duration of untreated psychosis is associated with a range of poor outcomes


Joe Judge appraises a recent systematic review and meta-analysis looking at the duration of untreated psychosis as a predictor of long-term outcomes in schizophrenia.

[read the full story...]

Second National Audit of Schizophrenia highlights lack of progress for service users and carers


André Tomlin summarises the second National Audit of Schizophrenia, which highlights that many people with schizophrenia are still not getting the high quality psychological and medical treatment they deserve.

[read the full story...]

Cognitive therapy is a non-stigmatising intervention for people at risk of psychosis


Criteria to identify subgroups experiencing an at-risk mental state (ARMS) have been developed and are widely adopted internationally, but this has fueled recent debates about unintended stigmatising consequences of identifying and providing treatment to people at risk of psychosis. While the Early Detection and Intervention Evaluation 2 (EDIE-2) trial has shown that cognitive therapy (CT) [read the full story…]

Individual CBT, with or without family CBT, could be the best first line treatment for people at high risk of schizophrenia

Colour transition

Schizophrenia is a debilitating illness that affects an estimated 25 million people worldwide. People with the condition can experience a huge amount of disability (both social, physical and psychological), but we know that early intervention can help reduce the duration of the illness and prevent further episodes of relapse. People with schizophrenia usually experience a [read the full story…]

Schizophrenia Commission report highlights what we can all do to improve care and understanding


The research and campaigns relating to life outcomes for people with schizophrenia and psychosis are truly shocking. It seems unbelievable that people with schizophrenia face a lifespan 15-20 years shorter than the general population and that only 7% are able to hold down a job. Paul Jenkins from Rethink Mental Illness sums it up nicely: [read the full story…]

CBT for people at ultra-high risk of psychosis: new RCT shows promise


Early intervention services for psychosis are aimed at people aged 14-35 who are experiencing a first episode of psychosis or at risk of doing so. The teams that work in this area usually include psychiatrists, psychologists, community psychiatric nurses, social workers and support workers. The NICE schizophrenia guideline recommends that early intervention services are offered [read the full story…]

Psychosis and schizophrenia in children and young people: NICE starts consultation


The two month consultation period for the new NICE guideline on psychosis and schizophrenia in children and young people has now begun. You must be registered as a stakeholder to comment on the guideline and you have until 27th September 2012 to make your views known. The guideline is aimed at clinicians and service commissioners [read the full story…]

New consensus guidelines on the pharmacological treatment of schizophrenia

shutterstock_11411980 consensus

The British Association for Psychopharmacology regularly publish consensus guidelines on the pharmacological treatment of mental health conditions. In the last two years these publications have included guidance on insomnia (PDF), dementia (PDF) and bipolar disorder (PDF). The latest guideline from the BAP is on the pharmacological treatment of schizophrenia and as usual it’s available in full-text [read the full story…]

Department of Health publish Mental Health Community Teams activity data

shutterstock_75335308 Male hand drawing a chart

The Department of Health have published the quarterly Mental Health Community Teams activity data for 2010-11 and 2011-12 quarter 1. The data consists of a number of spreadsheets and a document available for download from the DH website. The main findings were: 2010-11 During 2010-11 10,311 new cases of psychosis were served by Early Intervention [read the full story…]

Early intervention for psychosis: updated Cochrane review remains inconclusive

cochrane logo

The Cochrane Scizophrenia Group have updated the systematic review that brings together all randomised controlled trials (RCTs) designed to prevent progression to psychosis in people showing prodromal symptoms, or to improve outcome for people with first-episode psychosis. The reviewers found 18 RCTs this time around, but (as is often the case with systematic reviews) the [read the full story…]